ESC Premium Access

The emerging treatment landscape in ATTR amyloidosis: what’s on the horizon?

Topic: Chronic Heart Failure, Other
Organised by Medscape Education, supported by independent educational grants from Akcea Therapeutics, Alnylam Pharmaceuticals, Inc., and Eidos Therapeutics, Inc.

Presentation

About the speaker

Professor Claudio Rapezzi

University of Ferrara, Ferrara (Italy)
26 presentations
0 follower

4 more presentations in this session

Welcome and introduction - Amyloidosis beyond heart failure: paving the way for an early diagnosis.

Speaker: Doctor M. Grogan (Rochester, US)

Thumbnail

Delayed diagnosis of amyloidosis: what if the patient does not have heart failure?

Speaker: Doctor M. Grogan (Rochester, US)

Thumbnail

Managing amyloidosis in cardiology practice: a call for collaboration.

Speaker: Doctor M. Maurer (New York, US)

Thumbnail

Panel discussion and question and answer session - Amyloidosis beyond heart failure: paving the way for an early diagnosis.

Speaker: Doctor M. Grogan (Rochester, US)

Thumbnail

Access the full session

Amyloidosis beyond heart failure: paving the way for an early diagnosis

Speakers: Professor C. Rapezzi, Doctor M. Grogan, Doctor M. Grogan, Doctor M. Maurer, Doctor M. Grogan
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk